Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...

Forget one-size-fits-all cancer treatments — personalization is the future, and it’s already showing promise. In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful immune ...

Modifiable risk factors including obesity, diabetes, hypertension, smoking and a lack of exercise will contribute significantly to the doubling of kidney cancer cases around the world by 2050, ...